<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01452412</url>
  </required_header>
  <id_info>
    <org_study_id>2009-408</org_study_id>
    <secondary_id>R01DK087783</secondary_id>
    <nct_id>NCT01452412</nct_id>
  </id_info>
  <brief_title>Alkali Therapy in Chronic Kidney Disease</brief_title>
  <official_title>Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albert Einstein College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Albert Einstein College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Kidney disease is a common medical condition. Individuals with kidney disease develop a
      build-up of acid in their blood. This acid can affect their muscles, bones, glucose
      metabolism and kidneys. The investigators will test alkali treatment, to treat acid build-up,
      in a randomized placebo-controlled clinical trial to evaluate effects on muscles, bones,
      glucose metabolism and kidney.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sit to Stand to Sit Speed: Time Taken to Sit to Stand to Sit 10 Times</measure>
    <time_frame>2 year</time_frame>
    <description>Sit to stand to sit x10 speed (time to perform sit to stand to sit 10 times) will be measured and compared between groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DEXA of Wrist</measure>
    <time_frame>2 year</time_frame>
    <description>The investigators will evaluate changes in bone mineral density at the wrist.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hand-grip Strength</measure>
    <time_frame>2 year</time_frame>
    <description>Hand-grip strength will be measured in all participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated GFR</measure>
    <time_frame>2 year</time_frame>
    <description>Estimated GFR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life - Physical Function Domain</measure>
    <time_frame>2 year</time_frame>
    <description>Short Form- 36 (SF-36) will be performed in all participants. We will evaluate effects on the Physical Function Domain. The Physical Function Domain is scored from 0 to 100 with higher scores meaning better physical functioning.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">149</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>Metabolic Acidosis</condition>
  <arm_group>
    <arm_group_label>Sodium bicarbonate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.4 mEq/kg/day ideal body weight to be taken once a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo dosage/frequency equivalent to sodium bicarbonate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium bicarbonate</intervention_name>
    <description>0.4 mEq/kg/day ideal body weight to be taken once a day</description>
    <arm_group_label>Sodium bicarbonate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>To be taken on the same schedule as the active arm</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Estimate GFR &lt;= 45 and &gt;15 ml/min/1.73m2

          -  Age &gt;18

        Exclusion Criteria:

          -  Previous chronic treatment with alkali within the last 3 months (including sodium
             bicarbonate, calcium carbonate or baking soda)

          -  bicarbonate level &lt;20 or &gt;25 mEq/L

          -  New York Heart Association Class III or IV heart failure

          -  Systolic blood pressure &gt;180 mmHg

          -  Initiation of ESRD treatment planned within 6 months

          -  Kidney transplantation

          -  Treatment with immunosuppressives within the last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Hostetter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case Western Reserve University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Albert Einstein College of Medicine</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 12, 2011</study_first_submitted>
  <study_first_submitted_qc>October 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2011</study_first_posted>
  <results_first_submitted>November 13, 2019</results_first_submitted>
  <results_first_submitted_qc>December 19, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 7, 2020</results_first_posted>
  <last_update_submitted>December 19, 2019</last_update_submitted>
  <last_update_submitted_qc>December 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Albert Einstein College of Medicine</investigator_affiliation>
    <investigator_full_name>Michal L. Melamed</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Alkali</keyword>
  <keyword>Sodium bicarbonate</keyword>
  <keyword>Kidney disease</keyword>
  <keyword>Acidosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Acidosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sodium Bicarbonate</title>
          <description>0.4 mEq/kg/day ideal body weight to be taken once a day
Sodium bicarbonate: 0.4 mEq/kg/day ideal body weight to be taken once a day</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>placebo dosage/frequency equivalent to sodium bicarbonate
Placebo: To be taken on the same schedule as the active arm</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Initiated dialysis</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sodium Bicarbonate</title>
          <description>0.4 mEq/kg/day ideal body weight to be taken once a day
Sodium bicarbonate: 0.4 mEq/kg/day ideal body weight to be taken once a day</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>placebo dosage/frequency equivalent to sodium bicarbonate
Placebo: To be taken on the same schedule as the active arm</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="74"/>
            <count group_id="B2" value="75"/>
            <count group_id="B3" value="149"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.3" spread="14.1"/>
                    <measurement group_id="B2" value="61.6" spread="10.9"/>
                    <measurement group_id="B3" value="61" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="126"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serum bicarbonate</title>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" spread="2.2"/>
                    <measurement group_id="B2" value="24.1" spread="2.6"/>
                    <measurement group_id="B3" value="24" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>estimated glomerular filtration rate (eGFR)</title>
          <units>ml/min/1.73m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.2" spread="11.1"/>
                    <measurement group_id="B2" value="36.4" spread="11.4"/>
                    <measurement group_id="B3" value="36.3" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sit to Stand to Sit Speed: Time Taken to Sit to Stand to Sit 10 Times</title>
        <description>Sit to stand to sit x10 speed (time to perform sit to stand to sit 10 times) will be measured and compared between groups.</description>
        <time_frame>2 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium Bicarbonate</title>
            <description>0.4 mEq/kg/day ideal body weight to be taken once a day
Sodium bicarbonate: 0.4 mEq/kg/day ideal body weight to be taken once a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>placebo dosage/frequency equivalent to sodium bicarbonate
Placebo: To be taken on the same schedule as the active arm</description>
          </group>
        </group_list>
        <measure>
          <title>Sit to Stand to Sit Speed: Time Taken to Sit to Stand to Sit 10 Times</title>
          <description>Sit to stand to sit x10 speed (time to perform sit to stand to sit 10 times) will be measured and compared between groups.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.8" spread="5.8"/>
                    <measurement group_id="O2" value="22.9" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>DEXA of Wrist</title>
        <description>The investigators will evaluate changes in bone mineral density at the wrist.</description>
        <time_frame>2 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium Bicarbonate</title>
            <description>0.4 mEq/kg/day ideal body weight to be taken once a day
Sodium bicarbonate: 0.4 mEq/kg/day ideal body weight to be taken once a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>placebo dosage/frequency equivalent to sodium bicarbonate
Placebo: To be taken on the same schedule as the active arm</description>
          </group>
        </group_list>
        <measure>
          <title>DEXA of Wrist</title>
          <description>The investigators will evaluate changes in bone mineral density at the wrist.</description>
          <units>g/cm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" spread="0.23"/>
                    <measurement group_id="O2" value="0.73" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hand-grip Strength</title>
        <description>Hand-grip strength will be measured in all participants</description>
        <time_frame>2 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium Bicarbonate</title>
            <description>0.4 mEq/kg/day ideal body weight to be taken once a day
Sodium bicarbonate: 0.4 mEq/kg/day ideal body weight to be taken once a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>placebo dosage/frequency equivalent to sodium bicarbonate
Placebo: To be taken on the same schedule as the active arm</description>
          </group>
        </group_list>
        <measure>
          <title>Hand-grip Strength</title>
          <description>Hand-grip strength will be measured in all participants</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.3" spread="9.8"/>
                    <measurement group_id="O2" value="24.9" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimated GFR</title>
        <description>Estimated GFR</description>
        <time_frame>2 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium Bicarbonate</title>
            <description>0.4 mEq/kg/day ideal body weight to be taken once a day
Sodium bicarbonate: 0.4 mEq/kg/day ideal body weight to be taken once a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>placebo dosage/frequency equivalent to sodium bicarbonate
Placebo: To be taken on the same schedule as the active arm</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated GFR</title>
          <description>Estimated GFR</description>
          <units>ml/min/1.73m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.5" spread="17.7"/>
                    <measurement group_id="O2" value="36.3" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life - Physical Function Domain</title>
        <description>Short Form- 36 (SF-36) will be performed in all participants. We will evaluate effects on the Physical Function Domain. The Physical Function Domain is scored from 0 to 100 with higher scores meaning better physical functioning.</description>
        <time_frame>2 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sodium Bicarbonate</title>
            <description>0.4 mEq/kg/day ideal body weight to be taken once a day
Sodium bicarbonate: 0.4 mEq/kg/day ideal body weight to be taken once a day</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>placebo dosage/frequency equivalent to sodium bicarbonate
Placebo: To be taken on the same schedule as the active arm</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life - Physical Function Domain</title>
          <description>Short Form- 36 (SF-36) will be performed in all participants. We will evaluate effects on the Physical Function Domain. The Physical Function Domain is scored from 0 to 100 with higher scores meaning better physical functioning.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40" spread="12"/>
                    <measurement group_id="O2" value="43" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sodium Bicarbonate</title>
          <description>0.4 mEq/kg/day ideal body weight to be taken once a day
Sodium bicarbonate: 0.4 mEq/kg/day ideal body weight to be taken once a day</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>placebo dosage/frequency equivalent to sodium bicarbonate
Placebo: To be taken on the same schedule as the active arm</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>All-cause hospitalization</sub_title>
                <description>Hospitalizations were collected, not cause of hospitalization.</description>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="74"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Serum bicarbonate &gt;=30</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="74"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Serum bicarbonate &lt;=18</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="74"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Serum potassium &lt;=3.5</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="74"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Serum potassium &gt;= 5.0 mEq/L</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="74"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michal Melamed, MD</name_or_title>
      <organization>Albert Einstein College of Medicine</organization>
      <phone>718-430-2496</phone>
      <email>michal.melamed@einstein.yu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

